Literature DB >> 19481108

The dopaminergic basis of human behaviors: A review of molecular imaging studies.

Alice Egerton1, Mitul A Mehta, Andrew J Montgomery, Julia M Lappin, Oliver D Howes, Suzanne J Reeves, Vincent J Cunningham, Paul M Grasby.   

Abstract

This systematic review describes human molecular imaging studies which have investigated alterations in extracellular DA levels during performance of behavioral tasks. Whilst heterogeneity in experimental methods limits meta-analysis, we describe the advantages and limitations of different methodological approaches. Interpretation of experimental results may be limited by regional cerebral blood flow (rCBF) changes, head movement and choice of control conditions. We revisit our original study of striatal DA release during video-game playing [Koepp, M.J., Gunn, R.N., Lawrence, A.D., Cunningham, V.J., Dagher, A., Jones, T., Brooks, D.J., Bench, C.J., Grasby, P.M., 1998. Evidence for striatal dopamine release during a video game. Nature 393, 266-268] to illustrate the potentially confounding influences of head movement and alterations in rCBF. Changes in [(11)C]raclopride binding may be detected in extrastriatal as well as striatal brain regions-however we review evidence which suggests that extrastriatal changes may not be clearly interpreted in terms of DA release. Whilst several investigations have detected increases in striatal extracellular DA concentrations during task components such as motor learning and execution, reward-related processes, stress and cognitive performance, the presence of potentially biasing factors should be carefully considered (and, where possible, accounted for) when designing and interpreting future studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19481108      PMCID: PMC3797507          DOI: 10.1016/j.neubiorev.2009.05.005

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  229 in total

1.  In vivo binding behavior of dopamine receptor agonist (+)-PD 128907 and implications for the "ceiling effect" in endogenous competition studies with [(11)C]raclopride-a positron emission tomography study in Macaca mulatta.

Authors:  Rudie Kortekaas; R Paul Maguire; Thomas I Cremers; Durk Dijkstra; Aren van Waarde; Klaus L Leenders
Journal:  J Cereb Blood Flow Metab       Date:  2004-05       Impact factor: 6.200

Review 2.  Placebo mechanisms and reward circuitry: clues from Parkinson's disease.

Authors:  Raúl de la Fuente-Fernández; Michael Schulzer; A Jon Stoessl
Journal:  Biol Psychiatry       Date:  2004-07-15       Impact factor: 13.382

Review 3.  Computational roles for dopamine in behavioural control.

Authors:  P Read Montague; Steven E Hyman; Jonathan D Cohen
Journal:  Nature       Date:  2004-10-14       Impact factor: 49.962

Review 4.  DAncing past the DAT at a DA synapse.

Authors:  Stephanie J Cragg; Margaret E Rice
Journal:  Trends Neurosci       Date:  2004-05       Impact factor: 13.837

5.  Dopamine transmission in the human striatum during monetary reward tasks.

Authors:  David H Zald; Isabelle Boileau; Wael El-Dearedy; Roger Gunn; Francis McGlone; Gabriel S Dichter; Alain Dagher
Journal:  J Neurosci       Date:  2004-04-28       Impact factor: 6.167

6.  Binding characteristics of high-affinity dopamine D2/D3 receptor agonists, 11C-PPHT and 11C-ZYY-339 in rodents and imaging in non-human primates by PET.

Authors:  Jogeshwar Mukherjee; Tanjore K Narayanan; Bradley T Christian; Bingzhi Shi; Zhi-Ying Yang
Journal:  Synapse       Date:  2004-11       Impact factor: 2.562

7.  Change in binding potential as a quantitative index of neurotransmitter release is highly sensitive to relative timing and kinetics of the tracer and the endogenous ligand.

Authors:  Karmen K Yoder; Chunzhi Wang; Evan D Morris
Journal:  J Nucl Med       Date:  2004-05       Impact factor: 10.057

8.  Smoking-induced ventral striatum dopamine release.

Authors:  Arthur L Brody; Richard E Olmstead; Edythe D London; Judah Farahi; Jeffrey H Meyer; Paul Grossman; Grace S Lee; Joe Huang; Emily L Hahn; Mark A Mandelkern
Journal:  Am J Psychiatry       Date:  2004-07       Impact factor: 18.112

9.  Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain.

Authors:  Nora D Volkow; Gene-Jack Wang; Joanna S Fowler; Frank Telang; Laurence Maynard; Jean Logan; Samuel J Gatley; Naomi Pappas; Christopher Wong; Paul Vaska; Wei Zhu; James M Swanson
Journal:  Am J Psychiatry       Date:  2004-07       Impact factor: 18.112

10.  Effect of amphetamine on [(18)F]fallypride in vivo binding to D(2) receptors in striatal and extrastriatal regions of the primate brain: Single bolus and bolus plus constant infusion studies.

Authors:  Mark Slifstein; Raj Narendran; Dah-Ren Hwang; Yasuhiko Sudo; Peter S Talbot; Yiyun Huang; Marc Laruelle
Journal:  Synapse       Date:  2004-10       Impact factor: 2.562

View more
  62 in total

1.  Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder.

Authors:  Nora D Volkow; Gene-Jack Wang; Dardo Tomasi; Scott H Kollins; Tim L Wigal; Jeffrey H Newcorn; Frank W Telang; Joanna S Fowler; Jean Logan; Christopher T Wong; James M Swanson
Journal:  J Neurosci       Date:  2012-01-18       Impact factor: 6.167

2.  Anatomically distinct dopamine release during anticipation and experience of peak emotion to music.

Authors:  Valorie N Salimpoor; Mitchel Benovoy; Kevin Larcher; Alain Dagher; Robert J Zatorre
Journal:  Nat Neurosci       Date:  2011-01-09       Impact factor: 24.884

3.  Reliability of striatal [¹¹C]raclopride binding in smokers wearing transdermal nicotine patches.

Authors:  Karmen K Yoder; Daniel S Albrecht; David A Kareken; Lauren M Federici; Kevin M Perry; Elizabeth A Patton; Qi-Huang Zheng; Bruce H Mock; Sean J O'Connor; Christine M Herring
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-10-19       Impact factor: 9.236

4.  Abnormal striatal dopaminergic neurotransmission during rest and task production in spasmodic dysphonia.

Authors:  Kristina Simonyan; Brian D Berman; Peter Herscovitch; Mark Hallett
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

5.  Silver exposure in developing zebrafish produces persistent synaptic and behavioral changes.

Authors:  Christina M Powers; Edward D Levin; Frederic J Seidler; Theodore A Slotkin
Journal:  Neurotoxicol Teratol       Date:  2010-10-28       Impact factor: 3.763

Review 6.  Hypothesis: bacteria control host appetites.

Authors:  Vic Norris; Franck Molina; Andrew T Gewirtz
Journal:  J Bacteriol       Date:  2012-11-09       Impact factor: 3.490

7.  Connectivity-based functional analysis of dopamine release in the striatum using diffusion-weighted MRI and positron emission tomography.

Authors:  Andri C Tziortzi; Suzanne N Haber; Graham E Searle; Charalampos Tsoumpas; Christopher J Long; Paul Shotbolt; Gwenaelle Douaud; Saad Jbabdi; Timothy E J Behrens; Eugenii A Rabiner; Mark Jenkinson; Roger N Gunn
Journal:  Cereb Cortex       Date:  2013-01-02       Impact factor: 5.357

Review 8.  Genetic Variation and Neuroplasticity: Role in Rehabilitation After Stroke.

Authors:  Jill Campbell Stewart; Steven C Cramer
Journal:  J Neurol Phys Ther       Date:  2017-07       Impact factor: 3.649

9.  Multimodal MR imaging of brain iron in attention deficit hyperactivity disorder: a noninvasive biomarker that responds to psychostimulant treatment?

Authors:  Vitria Adisetiyo; Jens H Jensen; Ali Tabesh; Rachael L Deardorff; Els Fieremans; Adriana Di Martino; Kevin M Gray; Francisco X Castellanos; Joseph A Helpern
Journal:  Radiology       Date:  2014-06-17       Impact factor: 11.105

10.  Establishing test-retest reliability of an adapted [(18)F]fallypride imaging protocol in older people.

Authors:  Joel T Dunn; Chloe Clark-Papasavas; Paul Marsden; Stacey Baker; Marcel Cleij; Shitij Kapur; Robert Kessler; Robert Howard; Suzanne J Reeves
Journal:  J Cereb Blood Flow Metab       Date:  2013-04-17       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.